Search Results - "SEBTI, Said"
-
1
PTEN counteracts FBXL2 to promote IP3R3- and Ca 2+ -mediated apoptosis limiting tumour growth
Published in Nature (London) (22-06-2017)“…In response to environmental cues that promote IP3 (inositol 1,4,5-trisphosphate) generation, IP3 receptors (IP3Rs) located on the endoplasmic reticulum allow…”
Get full text
Journal Article -
2
PTEN counteracts FBXL2 to promote IP3R3- and Ca2+-mediated apoptosis limiting tumour growth
Published in Nature (London) (22-06-2017)“…PTEN, a known tumour suppressor, inhibits the FXBL2-dependent degradation of IP3R3, an IP3 receptor, thus augmenting IP3R3-mediated calcium release from the…”
Get full text
Journal Article -
3
The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells
Published in The Journal of biological chemistry (06-03-2020)“…In human cancer cells that harbor mutant KRAS and WT p53 (p53), KRAS contributes to the maintenance of low p53 levels. Moreover, KRAS depletion stabilizes and…”
Get full text
Journal Article -
4
Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation
Published in PloS one (19-03-2010)“…The AKT/PKB kinase is a key signaling component of one of the most frequently activated pathways in cancer and is a major target of cancer drug development…”
Get full text
Journal Article -
5
Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity
Published in Proceedings of the National Academy of Sciences - PNAS (01-05-2007)“…S3I-201 (NSC 74859) is a chemical probe inhibitor of Stat3 activity, which was identified from the National Cancer Institute chemical libraries by using…”
Get full text
Journal Article -
6
Ral GTPase Down-regulation Stabilizes and Reactivates p53 to Inhibit Malignant Transformation
Published in The Journal of biological chemistry (07-11-2014)“…Ral GTPases are critical effectors of Ras, yet the molecular mechanism by which they induce malignant transformation is not well understood. In this study, we…”
Get full text
Journal Article -
7
Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors
Published in Clinical cancer research (01-10-2019)“…Mutant KRAS is a major driver of pancreatic oncogenesis and therapy resistance, yet KRAS inhibitors are lacking in the clinic. KRAS requires farnesylation for…”
Get full text
Journal Article -
8
δ-Tocotrienol, a natural form of vitamin E, inhibits pancreatic cancer stem-like cells and prevents pancreatic cancer metastasis
Published in Oncotarget (09-05-2017)“…The growth, metastasis, and chemotherapy resistance of pancreatic ductal adenocarcinoma (PDAC) is characterized by the activation and growth of…”
Get full text
Journal Article -
9
MDMX Overexpression Prevents p53 Activation by the MDM2 Inhibitor Nutlin
Published in The Journal of biological chemistry (03-11-2006)“…The p53 tumor suppressor plays a key role in maintaining genomic stability and protection against malignant transformation. MDM2 and MDMX are both p53-binding…”
Get full text
Journal Article -
10
Combined HMG-COA reductase and prenylation inhibition in treatment of CCM
Published in Proceedings of the National Academy of Sciences - PNAS (23-05-2017)“…Cerebral cavernous malformations (CCMs) are common vascular anomalies that develop in the central nervous system and, more rarely, the retina. The lesions can…”
Get full text
Journal Article -
11
Vitamin E δ-tocotrienol augments the antitumor activity of gemcitabine and suppresses constitutive NF-κB activation in pancreatic cancer
Published in Molecular cancer therapeutics (01-12-2011)“…The NF-κB transcription factor functions as a crucial regulator of cell survival and chemoresistance in pancreatic cancer. Recent studies suggest that…”
Get full text
Journal Article -
12
Chk1 Inhibition Potently Blocks STAT3 Tyrosine705 Phosphorylation, DNA-Binding Activity, and Activation of Downstream Targets in Human Multiple Myeloma Cells
Published in Molecular cancer research (01-03-2022)“…The relationship between the checkpoint kinase Chk1 and the STAT3 pathway was examined in multiple myeloma cells. Gene expression profiling of U266 cells…”
Get full text
Journal Article -
13
Phase II Study of the Mitogen-Activated Protein Kinase 1/2 Inhibitor Selumetinib in Patients With Advanced Hepatocellular Carcinoma
Published in Journal of clinical oncology (10-06-2011)“…PURPOSE Hepatocellular carcinoma (HCC) is a common and deadly malignancy with few systemic therapy options. The RAF/mitogen-activated protein kinase kinase…”
Get full text
Journal Article -
14
Mevalonate Metabolism Regulates Basal Breast Cancer Stem Cells and Is a Potential Therapeutic Target
Published in Stem cells (Dayton, Ohio) (01-07-2012)“…There is increasing evidence that breast tumors are organized in a hierarchy, with a subpopulation of tumorigenic cancer cells, the cancer stem cells (CSCs),…”
Get full text
Journal Article -
15
Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine
Published in Cell death and differentiation (01-11-2018)“…The relative contribution of intrinsic genetic factors and extrinsic environmental ones to cancer aetiology and natural history is a lengthy and debated issue…”
Get full text
Journal Article -
16
Structure-based Design of High Affinity Peptides Inhibiting the Interaction of p53 with MDM2 and MDMX
Published in The Journal of biological chemistry (15-01-2010)“…MDM2 and MDMX function as key regulators of p53 by binding to its N terminus, inhibiting its transcriptional activity, and promoting degradation. MDM2 and MDMX…”
Get full text
Journal Article -
17
Inhibiting Isoprenylation Suppresses FcεRI-Mediated Mast Cell Function and Allergic Inflammation
Published in The Journal of immunology (1950) (15-08-2023)“…IgE-mediated mast cell activation is a driving force in allergic disease in need of novel interventions. Statins, long used to lower serum cholesterol, have…”
Get full text
Journal Article -
18
Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway
Published in Cancer research (Chicago, Ill.) (15-10-2005)“…Abnormal dendritic cell differentiation and accumulation of immunosuppressive myeloid cells in cancer is one of the major factors of tumor nonresponsiveness…”
Get full text
Journal Article -
19
Identification of novel inhibitors that disrupt STAT3-DNA interaction from a γ-AApeptide OBOC combinatorial library
Published in Chemical communications (Cambridge, England) (14-08-2014)“…From a γ-AApeptide-based one-bead-one-compound (OBOC) combinatorial library, we identified γ-AApeptides that can selectively inhibit STAT3-DNA interaction and…”
Get more information
Journal Article -
20
Development of Highly Potent and Selective Diaminothiazole Inhibitors of Cyclin-Dependent Kinases
Published in Journal of medicinal chemistry (23-05-2013)“…Cyclin-dependent kinases (CDKs) are serine/threonine protein kinases that act as key regulatory elements in cell cycle progression. We describe the development…”
Get full text
Journal Article